RDY Common Stock from 2010 to 2025

RDY Stock

USD 13.71 0.13 0.96%

Dr Reddys Common Stock yearly trend continues to be fairly stable with very little volatility. Common Stock is likely to outpace its year average in 2025. During the period from 2010 to 2025, Dr Reddys Common Stock regression line of annual values had r-squared of 0.06 and arithmetic mean of 1,285,960,597. View All Fundamentals

Common Stock

First Reported

2000-03-31

Previous Quarter

834 M

Current Value

834 M

Quarterly Volatility

1.1 B

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 2.1 B, Total Revenue of 337.1 B or Gross Profit of 197.6 B, as well as many indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0271 or PTB Ratio of 0.86. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.

Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Common Stock Growth Pattern

Below is the plot of the Common Stock of Dr Reddys Laboratories over the last few years. It is Dr Reddys' Common Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.

Common Stock

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Common Stock

Timeline

RDY Common Stock Regression Statistics

	Arithmetic Mean	1,285,960,597
	Geometric Mean	728,555,327
	Coefficient Of Variation	150.43
	Mean Deviation	900,754,925
	Median	834,000,000
	Standard Deviation	1,934,451,626
	Sample Variance	3742103.1T
	Range	8.5B
	R-Value	(0.24)
	Mean Square Error	3771244.4T
	R-Squared	0.06
	Significance	0.36
	Slope	(99,026,510)
	Total Sum of Squares	56131546.4T

RDY Common Stock History

	2025	1.1 B
	2024	959.1 M
	2023	834 M
	2022	833 M
	2020	832 M
	2019	831 M

Other Fundumenentals of Dr Reddys Laboratories

	Common Stock Shares Outstanding
	Common Stock Total Equity

Dr Reddys Common Stock component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Net Receivables	Good Will	Total Current Assets	Treasury Stock	Short Term Debt	Net Tangible Assets	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.1	0.97	-0.15	0.93	0.97	0.89	0.95	-0.06	-0.04	0.93	0.98	0.98	1.0	-0.06	0.93	0.07	-0.04	0.13	-0.18	-0.16	0.17	0.14	0.12	0.16
Total Stockholder Equity	0.98		0.29	0.91	-0.16	0.97	0.89	0.86	0.87	0.1	0.07	0.84	0.93	0.91	0.99	-0.23	0.83	0.22	0.08	0.01	-0.21	-0.1	0.19	0.31	0.29	0.3
Retained Earnings	0.1	0.29		-0.11	0.05	0.35	-0.15	0.07	-0.2	0.84	0.58	-0.24	-0.04	-0.11	0.13	-0.83	-0.26	0.69	0.63	-0.55	-0.06	0.33	0.04	0.83	0.85	0.7
Accounts Payable	0.97	0.91	-0.11		-0.13	0.85	1.0	0.9	0.99	-0.22	-0.15	0.97	0.99	0.99	0.96	0.11	0.97	-0.03	-0.15	0.24	-0.14	-0.22	0.15	0.0	-0.02	0.0
Long Term Debt	-0.15	-0.16	0.05	-0.13		-0.24	-0.13	0.18	-0.16	0.38	0.07	-0.06	-0.18	-0.15	-0.19	0.12	-0.16	-0.01	0.19	-0.21	0.99	0.44	-0.49	-0.13	-0.13	-0.07
Short Term Investments	0.93	0.97	0.35	0.85	-0.24		0.83	0.74	0.81	0.07	-0.01	0.76	0.88	0.85	0.95	-0.22	0.76	0.2	-0.03	-0.08	-0.3	-0.12	0.37	0.39	0.37	0.38
Total Liab	0.97	0.89	-0.15	1.0	-0.13	0.83		0.89	1.0	-0.25	-0.16	0.98	0.99	0.99	0.95	0.15	0.99	-0.08	-0.16	0.26	-0.14	-0.23	0.12	-0.07	-0.09	-0.04
Intangible Assets	0.89	0.86	0.07	0.9	0.18	0.74	0.89		0.85	0.11	0.04	0.88	0.89	0.88	0.86	-0.01	0.85	0.11	0.16	0.14	0.17	-0.02	-0.07	0.07	0.07	0.04
Common Stock	0.95	0.87	-0.2	0.99	-0.16	0.81	1.0	0.85		-0.31	-0.21	0.98	0.97	0.99	0.94	0.2	0.99	-0.14	-0.23	0.29	-0.16	-0.26	0.14	-0.13	-0.15	-0.06
Property Plant Equipment	-0.06	0.1	0.84	-0.22	0.38	0.07	-0.25	0.11	-0.31		0.64	-0.3	-0.17	-0.22	-0.06	-0.71	-0.33	0.71	0.76	-0.51	0.33	0.67	-0.24	0.59	0.62	0.45
Current Deferred Revenue	-0.04	0.07	0.58	-0.15	0.07	-0.01	-0.16	0.04	-0.21	0.64		-0.22	-0.06	-0.13	-0.03	-0.81	-0.23	0.62	0.74	-0.42	0.08	0.34	-0.58	0.38	0.46	0.07
Net Debt	0.93	0.84	-0.24	0.97	-0.06	0.76	0.98	0.88	0.98	-0.3	-0.22		0.94	0.97	0.91	0.23	0.98	-0.17	-0.19	0.37	-0.06	-0.3	0.07	-0.18	-0.19	-0.09
Net Receivables	0.98	0.93	-0.04	0.99	-0.18	0.88	0.99	0.89	0.97	-0.17	-0.06	0.94		0.98	0.97	0.03	0.95	0.04	-0.1	0.17	-0.19	-0.19	0.14	0.07	0.06	0.03
Good Will	0.98	0.91	-0.11	0.99	-0.15	0.85	0.99	0.88	0.99	-0.22	-0.13	0.97	0.98		0.96	0.11	0.98	-0.07	-0.15	0.24	-0.15	-0.21	0.13	-0.06	-0.08	-0.01
Total Current Assets	1.0	0.99	0.13	0.96	-0.19	0.95	0.95	0.86	0.94	-0.06	-0.03	0.91	0.97	0.96		-0.09	0.91	0.1	-0.04	0.11	-0.23	-0.18	0.2	0.18	0.16	0.19
Treasury Stock	-0.06	-0.23	-0.83	0.11	0.12	-0.22	0.15	-0.01	0.2	-0.71	-0.81	0.23	0.03	0.11	-0.09		0.26	-0.84	-0.76	0.39	0.18	-0.25	0.19	-0.76	-0.81	-0.42
Short Term Debt	0.93	0.83	-0.26	0.97	-0.16	0.76	0.99	0.85	0.99	-0.33	-0.23	0.98	0.95	0.98	0.91	0.26		-0.21	-0.22	0.34	-0.15	-0.26	0.13	-0.2	-0.23	-0.11
Net Tangible Assets	0.07	0.22	0.69	-0.03	-0.01	0.2	-0.08	0.11	-0.14	0.71	0.62	-0.17	0.04	-0.07	0.1	-0.84	-0.21		0.68	-0.22	-0.07	0.41	-0.16	0.76	0.8	0.41
Long Term Investments	-0.04	0.08	0.63	-0.15	0.19	-0.03	-0.16	0.16	-0.23	0.76	0.74	-0.19	-0.1	-0.15	-0.04	-0.76	-0.22	0.68		-0.08	0.16	0.27	-0.36	0.51	0.53	0.25
Short Long Term Debt	0.13	0.01	-0.55	0.24	-0.21	-0.08	0.26	0.14	0.29	-0.51	-0.42	0.37	0.17	0.24	0.11	0.39	0.34	-0.22	-0.08		-0.18	-0.56	0.03	-0.39	-0.43	-0.27
Long Term Debt Total	-0.18	-0.21	-0.06	-0.14	0.99	-0.3	-0.14	0.17	-0.16	0.33	0.08	-0.06	-0.19	-0.15	-0.23	0.18	-0.15	-0.07	0.16	-0.18		0.45	-0.53	-0.25	-0.24	-0.2
Capital Surpluse	-0.16	-0.1	0.33	-0.22	0.44	-0.12	-0.23	-0.02	-0.26	0.67	0.34	-0.3	-0.19	-0.21	-0.18	-0.25	-0.26	0.41	0.27	-0.56	0.45		-0.26	0.1	0.13	0.03
Cash And Equivalents	0.17	0.19	0.04	0.15	-0.49	0.37	0.12	-0.07	0.14	-0.24	-0.58	0.07	0.14	0.13	0.2	0.19	0.13	-0.16	-0.36	0.03	-0.53	-0.26		0.26	0.2	0.26
Net Invested Capital	0.14	0.31	0.83	0.0	-0.13	0.39	-0.07	0.07	-0.13	0.59	0.38	-0.18	0.07	-0.06	0.18	-0.76	-0.2	0.76	0.51	-0.39	-0.25	0.1	0.26		0.98	0.72
Net Working Capital	0.12	0.29	0.85	-0.02	-0.13	0.37	-0.09	0.07	-0.15	0.62	0.46	-0.19	0.06	-0.08	0.16	-0.81	-0.23	0.8	0.53	-0.43	-0.24	0.13	0.2	0.98		0.65
Capital Stock	0.16	0.3	0.7	0.0	-0.07	0.38	-0.04	0.04	-0.06	0.45	0.07	-0.09	0.03	-0.01	0.19	-0.42	-0.11	0.41	0.25	-0.27	-0.2	0.03	0.26	0.72	0.65

Click cells to compare fundamentals

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Common Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Common Stock	959.1 M	1.1 B
Common Stock Shares Outstanding	958.6 M	1 B
Common Stock Total Equity	956.8 M	522.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

RDY Common Stock from 2010 to 2025

Latest Dr Reddys' Common Stock Growth Pattern

RDY Common Stock Regression Statistics

RDY Common Stock History

Other Fundumenentals of Dr Reddys Laboratories

Dr Reddys Common Stock component correlations

About Dr Reddys Financial Statements

Also Currently Popular

Additional Tools for RDY Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY